Clinical Trial Update: Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating stereotactic ablative radiotherapy for comprehensive treatment of 4-10 oligometastatic tumors; the study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: David Palma | Conditions: Metastatic Tumors | Phase 3 | Status: ACTIVE_NOT_RECRUITING